Transcript Highlights:

• resolution, the medical disclosure panel, is that something that there's an interest to introduce pharmaceutical
• resolution, the medical disclosure panel, is that something that there's an interest to introduce pharmaceutical
• Because, as I'm understanding, that is established for procedures and surgeries, not necessarily pharmaceuticals
• And including pharmaceuticals in that review panel, if that's the intention, would there be a change

Bills: HR267, HCR105, HCR107, HCR110, HCR113, HCR114, SB4, SB52, SB57, SB145, SB152, SB194, SB237, SB333, SB433, SB483, SCR37

Keywords: diabetes, amputation, amputations, diabetic foot ulcer, peripheral artery disease, PAD, wound care, podiatry, vascular disease, endocrinology, limb salvage, health policy, public health, healthcare costs, insurance coverage, Louisiana Department of Health, University of Louisiana at Lafayette, Louisiana Center for Health Innovation, patient education, screening

Transcript Highlights:

• requirements for veterinary technicians to continuing education, recordkeeping, humane care, and pharmaceutical
• education, recordkeeping, humane<00:25:00.240><c> care</c><00:25:00.559><c> and</c><00:25:00.799><c> pharmaceutical
• </c> humane care and pharmaceutical handling. humane care and pharmaceutical handling.

Keywords: 1187, senate, all

Transcript Highlights:

• Um and um so if we had an event, a legislative event outside the state compound, it would still give
• Um and um so if we had an event, a legislative event outside the state compound, it would still give
• event outside an event, a legislative event outside the<00:12:52.880><c> state</c><00:12:53.200><c> compound
• it</c><00:12:54.240><c> would</c><00:12:54.399><c> still</c><00:12:54.639><c> give</c> the state compound
• , it would still give the state compound, it would still give the<00:12:55.040><c> security</c><00:12

Bills: SB86, SB196, SB228, SB231, HB73, HB407, HB435, SB86, SB196, SB228, SB231, HB73, HB407, HB435

Keywords: independent contractors, portable benefits, employee benefits, tax deductions, employment relationship, education, high school, community college, dual enrollment, secondary credit, Move on When Ready, financial services, discrimination, social credit score, religious freedom, transparency, consumer rights, Alabama, wastewater management, public service commission

Transcript Highlights:

• We run about 3,500 trucks across the country, primarily hauling food and pharmaceuticals, and the second

Keywords: Highways and Transportation - Room 216, 25 March, 2026; 11:45 AM, 925, all

Transcript Highlights:

• is quite expensive, then oftentimes there are coupons or other help that is available through pharmaceutical

Summary: The House Health and Welfare Committee met with a quorum and first took up House Bill 558, sponsored by Representative Tanner. The bill concerns Social Security survivor benefits for foster youth and aims to ensure those funds are preserved for the children rather than used by the state for administrative purposes. In response to questions, Tanner said the measure applies to foster youth survivor benefits and can include benefits tied to a deceased veteran as well. He also said there is no specific federal guidance, and described the bill as codifying an existing Idaho executive action. The committee voted to send HB 558 to the floor with a due pass recommendation. The committee then heard RS 33377 from Representative Cannon, a bill draft to ban copay accumulator practices in health insurance. Cannon explained that these programs prevent third-party assistance, such as manufacturer coupons, from counting toward a patient’s deductible or out-of-pocket maximum, shifting the benefit away from patients. He said the proposal was brought by a constituent, had been worked on with Representative Furman, and would align Idaho with similar laws in other states and with pending federal legislation. Representative Furman moved to introduce the bill draft, and the committee approved the motion. After the introduction vote, the chair noted the bipartisan sponsorship and the committee adjourned.

Transcript Highlights:

• . >> CHRIS WITH PHARMACEUTICAL COMPANY WAIVES IN SUPPORT. FSU IN SUPPORT. WAIVE IN SUPPORT.

Keywords: 999, senate, all

Transcript Highlights:

• regulation related to kratom, a derivative of the Mitragyna speciosa tree containing psychoactive compounds
• regulation related to kratom, a derivative of the Mitragyna speciosa tree containing psychoactive compounds
• substance is okay at that half a percent— Is it still possible that they can, that an individual could compound
• know if that's preventable or if that's just part of the chemistry of of substances that people compound
• multiple naloxone doses, but that’s why I think it’s imperative that we follow the DEA’s lead on those compounds

Summary: The working group met for a legislative-only discussion on kratom ahead of a special session, with members first hearing a staff memo summarizing federal and state regulation, kratom’s psychoactive effects, reported health risks, and North Dakota’s recent executive action and special session call. The chair explained that legislators in the room would speak first, then online participants, with comments limited to about five to seven minutes, and noted a public open house and later expert testimony would follow. Several legislators argued the issue had already been extensively debated in the 2025 session, citing House Bill 1101, which would have scheduled kratom as a Schedule I substance and was defeated, and House Bill 1566, which evolved into a study. They urged the group to consider both prohibition and regulation, and some suggested a temporary measure until the 2027 session. Others emphasized testimony from people who say natural kratom helps with chronic pain or PTSD and warned against banning a product that some use to function, while still supporting tighter controls on adulterated or synthetic products. Other members focused on public health and enforcement concerns. Some said the executive order created confusion for users, retailers, and law enforcement, and raised concerns about withdrawal, access to treatment such as Suboxone, and whether the state could regulate the product effectively in the short time available. A pharmacology-focused discussion distinguished natural kratom leaf from synthetic 7-OH products, with several members saying the synthetic forms pose the greatest overdose risk and should be tightly restricted or scheduled, while any legal natural product would need strict limits, labeling, and penalties. The meeting ended without a vote, with the chair saying the group would continue gathering testimony and return for further hearings next week and during the special session.

Transcript Highlights:

• flooding, damage property, or harm wildlife, and two, the proposed operation will use chemicals, compounds
• statement that affirms its review of the application and proposed use and quantity of the chemical compounds
• The bill outlines, finally, that ADQ oversight over the chemicals, compounds, or substances that may
• The bill requires ADEQ to develop a list of approved chemicals and compounds and the maximum quantity
• The bill requires ADEQ to develop a list of approved chemicals and compounds and the maximum quantity

Bills: SB1005, SB1202, SB1278, SB1279, SB1280, SB1287

Keywords: cosmetics, animal testing, prohibition, manufacturers, sales regulation, state preemption, groundwater, water conservation, Arizona water resources, drought management, water quality, solar radiation management, environment, regulation, Arizona Revised Statutes, weather modification, licensing, environmental impact, public safety, cloud seeding

Transcript Highlights:

• of Health are implementing some programs they want to put in place on data tracking related to pharmaceutical
• That's especially important, I think, when it comes to pharmaceutical benefits.
• That's especially important, I think, when it comes to pharmaceutical benefits because of the way that

Keywords: 965, house, all

Transcript Highlights:

• So my feeling is that they're the big companies, the big pharmaceutical companies, companies that have
• companies do indeed engage in this, and this is a Senate report that’s there in the inset about a pharmaceutical
• One story I heard was about a company that was looking for venture capital to open up a pharmaceutical

Summary: The joint informational hearing examined California’s taxation of multinational corporations, especially the Water’s Edge election versus worldwide combined reporting. Chairs opened by framing the issue as a review of whether current rules fairly and sufficiently tax foreign subsidiary income, given profit shifting concerns, budget pressures, and the long history since Water’s Edge was adopted in the 1980s. The first panel from the Legislative Analyst’s Office and Franchise Tax Board explained the mechanics of unitary taxation, apportionment, and the Water’s Edge election, and provided filing data showing Water’s Edge filers are a small share of returns but account for a large share of corporate tax liability. FTB witnesses said the agency already administers both methods and could handle a shift to mandatory worldwide reporting with education and outreach, though revenue estimates are difficult because foreign affiliate information is not directly available. Committee members asked about foreign government pushback, administrative burden, industries with more profit shifting, revenue uncertainty, and whether companies would leave California. LAO and FTB witnesses said pushback from foreign governments was plausible, but they did not expect major business flight because California’s tax is largely based on sales rather than physical presence. They also said worldwide reporting could reduce profit shifting but might increase revenue volatility and litigation risk. A second panel of academic and tax policy witnesses argued that Water’s Edge is a loophole that rewards aggressive tax planning, that worldwide combined reporting would better capture income tied to California, and that modern federal and international rules such as NCTI/GILTI, CAMT, and Pillar Two reduce compliance concerns and make a return to worldwide reporting more feasible. They also said California’s current system can create selection effects and may under-tax large multinationals. In the next panel, a California Budget and Policy Center witness urged eliminating the Water’s Edge election, calling it a costly loophole that benefits large global corporations over smaller domestic businesses and deprives the state of billions in revenue that could support health care and other services. A Silicon Valley Leadership Group witness gave historical context for why Water’s Edge was adopted and began outlining concerns about compliance, double taxation, and the risk of overreaching beyond income truly connected to California. No bill was voted on or advanced; the hearing was informational only, with members using the testimony to weigh the policy trade-offs and possible transition periods if the Legislature were to change the current rules.

Transcript Highlights:

• So my feeling is that they're the big companies, the big pharmaceutical companies, companies that have
• companies do indeed engage in this, and this is a Senate report that's there in the inset about a pharmaceutical
• One story I heard was about a company that was looking for venture capital to open up a pharmaceutical

Keywords: 988, house, all

Transcript Highlights:

• So my feeling is that they're the big companies, the big pharmaceutical companies, companies that have
• companies do indeed engage in this, and this is a Senate report that's there in the inset about a pharmaceutical
• One story I heard was about a company that was looking for venture capital to open up a pharmaceutical

Summary: The joint informational hearing examined California’s taxation of multinational corporations, especially the state’s water’s-edge election versus worldwide combined reporting. The LAO and Franchise Tax Board explained the basic mechanics of unitary taxation, apportionment, and how water’s-edge generally excludes most foreign subsidiaries while worldwide reporting includes the full unitary group. FTB officials said water’s-edge filers are a small share of corporate filers but account for a large share of tax liability, and they described filing trends, industry mix, and the administrative steps needed to administer either system. Members and witnesses debated the policy trade-offs. Supporters of moving away from water’s-edge argued that it enables profit shifting, especially for large multinational and IP-heavy firms, and that eliminating it could raise significant revenue and improve fairness for smaller domestic businesses. They cited estimates of billions in potential revenue and said California already has the audit and reporting infrastructure to handle worldwide reporting, though some transition time would be needed. Opponents argued that worldwide reporting would tax foreign activity unrelated to California, create double taxation, increase compliance burdens and litigation, and could be difficult for foreign-based multinationals to document. They also warned that some of the revenue estimates are highly uncertain because foreign affiliate income is not directly observable. Committee members asked about foreign government pushback, the risk of companies leaving California, the effect on intellectual property shifting, and whether federal or Supreme Court action could block a change. Witnesses generally said major firms would be unlikely to leave because California taxes sales rather than physical presence, but some costs could be passed on to consumers. The panel also discussed alternatives such as conforming to federal international tax rules like NCTI/GILTI and adding anti-abuse rules. No vote or bill action was taken; the hearing was informational only.

Transcript Highlights:

• I think that they're the big companies, the big pharmaceutical companies, companies that have IP that's
• companies do indeed engage in this, and this is a Senate report that’s there in the inset about a pharmaceutical
• One story I heard was about a company that was looking for venture capital to open up a pharmaceutical

Summary: The joint informational hearing focused on California’s taxation of foreign subsidiaries of U.S. corporations, especially the state’s water’s-edge election versus worldwide combined reporting. Committee members and witnesses discussed how unitary taxation and sales-factor apportionment work, why multinational corporations are a small share of filers but a large share of tax liability, and how foreign income, profit shifting, and double taxation concerns affect policy choices. The Franchise Tax Board explained current filing rules, the seven-year water’s-edge election, and recent filing statistics showing about 21,562 water’s-edge returns in 2023, roughly 6% of C corporation filers but about half of corporate tax liability. The Legislative Analyst’s Office and FTB staff emphasized that revenue effects from eliminating water’s edge are uncertain because foreign affiliate income is not directly observable, and they noted possible revenue volatility and administrative complexity. Several committee members asked about foreign government pushback, the burden on FTB, whether certain industries are more likely to shift profits, and whether companies would leave California; witnesses generally said there was no strong evidence that firms would exit the state because tax liability is driven mainly by California sales. They also discussed how California already administers both methods, how the election can be advantageous or disadvantageous depending on a firm’s facts, and how federal reforms like GILTI/NCTI, CAMT, and OECD Pillar Two may affect the issue. The second panel presented sharply contrasting views. One professor and a tax policy advocate argued that water’s edge creates unfairness, encourages profit shifting, and leaves California with billions in lost revenue, while a Tax Foundation witness argued that mandatory worldwide reporting would tax the wrong income, create double taxation and litigation risk, and impose heavy compliance burdens, especially for foreign-based multinationals. A later panel from the California Budget and Policy Center supported closing the “water’s-edge loophole,” saying it would raise needed revenue for public services and level the playing field between large multinationals and smaller domestic businesses. No vote or formal action was taken; the hearing was informational only.

Transcript Highlights:

• My name is Jeremy Browning, and I represent Otsuka America Pharmaceuticals, and we stand in support of
• And when I mean overall spend, I mean pharmaceutical spend, emergency room, and hospital access.
• zero, what ultimately happens is a large fiscal note that looks at the increase in potential pharmaceutical

Bills: SB1086, SB1193, SB1318, SB1345, SB1346, SB1451, SB1496, SB1611, SB1630, SB1631, SB1632, SB1672

Keywords: reimbursement, healthcare, laboratory services, noncontracting providers, Arizona health care cost containment, personal identifying information, PII, privacy, confidential records, public records exemption, commercial disclosure, data privacy, licensure, certification, health professions, health care licensing, Arizona Department of Health Services, ADHS, emergency medical care technician, EMCT

Transcript Highlights:

• Firefighting foam, pharmaceuticals, and paper products have all been proven to be carcinogenic.
• You've got pharmaceutical agents which we know don't break down.
• ...mixed with manufacturing waste, mixed with pharmaceutical waste, mixed with industrial waste.

Bills: HB1341, HB1674, HB4028, SB2321

Keywords: hydrogen sulfide, public health, environmental regulation, Texas Commission on Environmental Quality, ground level concentrations, emissions limit, emissions limits, ground-level concentrations, air quality, PFAS, agriculture, environmental protection, health risks, criminal offense, chemical regulation, preproduction plastic, water quality, pollution control, industrial waste, emissions

Transcript Highlights:

• That's how they buy all their pharmaceutical products.
• That's how they buy all their pharmaceutical products.
• That's how they buy all their pharmaceutical products.
• That's how they buy all their pharmaceutical products.
• <02:19:38.840><c> companies</c><02:19:39.639><c> really</c><02:19:39.840><c> don't</c> pharmaceutical

Keywords: 928, house, all

Summary: The committee heard testimony on House Bill 224, which would redirect most money from New Hampshire’s renewable energy fund back to electric ratepayers. The bill sponsor argued the measure would lower energy costs, noting recent utility rate increases and estimating annual savings of roughly $2.5 million to $7.3 million for ratepayers. Supporters said the fund has accumulated money that should be returned to customers rather than used for subsidies, and they emphasized that the state has already rebated similar funds from RGGI for years. Opponents, including Rep. Kat McGee, argued the renewable energy fund is a successful, nonlapsing dedicated fund that supports local clean-energy projects, energy resilience, emissions reductions, and private investment. McGee said the fiscal note overstated the benefit of rebates and understated the loss of investment, claiming the average annual rebate would amount to less than $10 per customer while the program has helped leverage significant private dollars and nearly 10,000 projects. She urged the committee to reject the bill as a poor deal for the state and ratepayers. Committee members questioned the fiscal note, the size of the rebate, whether the bill would set a precedent for other dedicated funds, and whether the program’s incentives amount to picking winners and losers. The Department of Energy testified neutrally, explaining how the renewable energy fund works, including renewable energy credits, alternative compliance payments, and the fund’s use for renewable energy initiatives. No vote was taken in the portion of the hearing provided.

Transcript Highlights:

• Yeah, that's the act that protects pharmaceutical companies from being sued for adverse... ...that protects
• pharmaceutical companies from being sued for adverse reactions and side effects that should have been

Summary: The Senate convened with prayer, the Pledge of Allegiance, and a recorded roll call showing 28 present, 0 absent, and 2 excused. The chamber approved the journal and then took up several motions to reconsider or return bills, including requests to return HB 2035 and HB 2249 to the House and to reconsider HB 2192. The Senate then moved into Committee of the Whole for calendar items. In Committee of the Whole, members considered HB 2248, a public health mandates bill; HB 2313, concerning school employee/teacher strike and remote instruction issues; HB 2379, relating to school district governing board training; HB 2380, relating to school district board meetings and expenditures; and HB 2720, relating to prostitution assessments and the anti-human trafficking fund. HB 2248 drew the most debate over whether it would prohibit schools, employers, and medical facilities from requiring medical interventions such as vaccines; an amendment narrowing the definition of medical intervention was adopted, and the bill advanced. HB 2379 and HB 2380 both received committee and floor amendments focused on school board training and livestreaming/meeting transparency requirements, and HB 2313 and HB 2720 also advanced. The Committee of the Whole reported all four bills as do pass, with HB 2248, HB 2379, and HB 2380 as amended. The Senate then adopted the Committee of the Whole report after defeating an amendment that would have changed the HB 2248 recommendation to fail. The chamber next considered HCM 2001 and HCM 2002, memorials urging federal terrorist designations for the Muslim Brotherhood and CAIR, and HCR 2047, recognizing Judea and Samaria; all three passed despite strong opposition speeches criticizing them as targeting Muslim communities or advancing religious/political messaging. The Senate also passed HB 2118 on mobile food vendors, HCM 2009 on mineral access and federal land withdrawals, HCR 2015 on school physical activity and dietary guidelines, HCR 2020 on housing outside designated provider service areas with assured water supply, and HCR 2057 supporting next-generation geothermal energy. Finally, the Senate passed HB 2248, HB 2379, and HB 2380 on third reading, approved the House’s request to adjourn, and adjourned until April 21, 2026.

Transcript Highlights:

• Yeah, that's the act that protects pharmaceutical companies from being sued for adverse... ...that protects
• pharmaceutical companies from being sued for adverse reactions and side effects that should have been

Keywords: 1182, all

Transcript Highlights:

• The cost of pharmaceutical drugs alone continues to be one of the largest areas of cost growth, which
• In this particular amendment, Neighbor Health has offered a pharmaceutical tech program for local high

Summary: The Senate considered a supplemental appropriations bill and a series of amendments focused on education, health, transportation, and tax administration. Senator Kennedy spoke in support of increasing funding for DTA caseworkers to improve SNAP access and reduce errors, citing food insecurity and staffing shortages, but then withdrew the amendment by unanimous consent. Senator O’Connor’s amendment providing $500,000 for Free Period to supply menstrual products in public schools was adopted, as was Senator Miranda’s $1 million METCO transportation and student support amendment. Senator Collins withdrew an amendment to extend paid family and medical leave and unemployment insurance to graduate student workers. Other adopted amendments included funding for Bridgewater Middle School water filtration, Randolph High School restroom improvements, Uffum’s Corner Health Center, and NeighborHealth’s student pharmacy technician program. Several amendments were debated and rejected after standing votes. Senator Tarr proposed oversight and reporting requirements for the Group Insurance Commission and the MBTA deficiency fund, as well as a 90-day notice requirement for tax-code decoupling with major fiscal impacts; all were opposed and not adopted. Senator Rodrigues and Senator Crighton argued that the GIC and MBTA already have oversight mechanisms and need flexibility, while Tarr argued the measures would improve transparency and fiscal discipline. Senator DiDomenico withdrew a Chapter 70 education funding amendment after speaking about declining enrollment, school funding losses, and the need to protect gateway city districts; he also used the opportunity to reaffirm support for gender-affirming care funding. Senators Collins and others echoed concerns about school funding inequities and the need for future action. The Senate also adopted a motion to adjourn in memory of Arthur H. Tobin, a former Quincy mayor, state representative, state senator, and longtime clerk magistrate of Quincy District Court, with a detailed tribute to his public service and military record. After all amendments were resolved, the Senate substituted the new draft, ordered the bill to a third reading, and then passed House No. 5280 to be engrossed by a roll call vote of 35-4. The chamber then agreed to adjourn until the following Monday at 11 a.m., with the clerk directed not to print a calendar.

Transcript Highlights:

• And the federal government has not done the science, nor has the pharmaceutical industry, that needs
• With the swinging door policy of the FDA and pharmaceutical companies, it's very easy to see that.

Summary: The House Health and Welfare Committee first heard Senate Bill 1292, which would require prospective foster parents to complete 10 hours of basic training before licensure, replacing the current practice where most training is available but optional. Senator Brandon Shippey said the bill was developed with the Department of Health and Welfare as a middle ground between burdensome in-person training and no training at all, with the goal of improving foster parent retention and child safety. A foster parent testified in support, describing crises among new foster families who had not taken training. The committee moved the bill to the floor with a due pass recommendation, and it passed unanimously. The committee then took up House Bill 862, creating an Idaho Rural Health Transformation Fund and oversight committee for federal rural health transformation dollars. Rep. Jordan Redmond said the bill was intended to give the legislature oversight of nearly $1 billion in federal funds over five years and to ensure grants include sustainability plans. Members raised concerns about whether the state should accept the funds at all, whether committee members would be paid, and what happens when the money runs out. Supporters argued the bill was about legislative oversight and accountability, while opponents warned it resembled unsustainable federal spending and criticized the underlying federal program. The bill was sent to the floor with a due pass recommendation, with three no votes recorded. The committee began hearing House Bill 808, an expanded medical freedom bill that would make school and daycare immunizations voluntary, make the immunization registry opt-in rather than opt-out, and limit local governments from imposing medical mandates. The sponsor and supporters said the bill would protect informed consent, prevent coercion, and clarify that the Medical Freedom Act applies statewide. Opponents, including pediatricians, nurses, and school nurses, argued it would weaken public health protections, reduce immunization rates, and make it harder to track and prevent outbreaks. An insurer and other witnesses also warned that the bill’s language could unintentionally restrict emergency responders and public hospitals from recommending or providing medical care. The committee did not finish testimony and recessed, planning to continue the hearing the next day.